[16205] in athena10
=?UTF-8?Q?IVST_by_Super_Majority_Vote,_Boosting_Innovest=E2=80=99s_Revenu?=
daemon@ATHENA.MIT.EDU (Dominique Bailey)
Sun Dec 30 16:13:12 2018
Date: Sun, 30 Dec 2018 13:27:05 +0000
To: <debathena@mit.edu>
From: Dominique Bailey <noreply@ivst.site>
Reply-To: <noreply@ivst.site>
Message-ID: <d6fbdc249308baba7b1b754d555fd497@ivst.site>
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="b1_1a3ab4d379a91838ba6266608615c1eb"
--b1_1a3ab4d379a91838ba6266608615c1eb
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
Trouble viewing this email? Click here to see this message online!
Innovest Global, Inc. =C2=A0$IVST is a diversified Public Holding company t=
hat is already a ten-bagger this year with much more on the way based on fu=
ndamentals AND technicals!
IVST massive breaking news:
IVST The Board of =E2=80=98Authority National Supply=E2=80=99 Approves Pend=
ing Company Sale to IVST by Super Majority Vote, Boosting Innovest=E2=80=
=99s Revenue by $30 Million Annually.
Innovest Global Provides Acquisition Update: Authority National Supply Clos=
ing Rescheduled to First Week of November and Secured LOI for $12 Million R=
evenue and Profitable Acquisition in the Building Industry
Innovest Global, Inc. (OTC Markets: IVST) is in the Conglomerates industry,=
a diversified holding company with operations in commercial and industrial=
products and services, energy, biotechnology, and health services. Our pri=
mary growth strategy is to acquire niche, high-growth businesses that are c=
apable of generating significant annual revenue. Planned subsidiaries opera=
te across telehealth, biotech, building materials, commercial energy, busin=
ess-to-business distribution, national call center and auto sales.
Based out of Cleveland, Ohio, IVST is easily one of the better fundamental =
companies trading on the OTC marketplace. Innovest Global, Inc. is already =
up 10-fold in 2018, after starting off 2018 around $0.02 before shooting to=
an all-time high of $0.50 in March 2018. IVST continues to hold onto the n=
ice gains thus far holding strong in the .25-.30 range ready for the next l=
eg back into the .50 range it tested earlier this year. Based upon the comp=
any=E2=80=99s strong fundamental AND technical picture, Innovest Global, In=
c. could easily retake its all-time high by the end of 2018.
What a stock structure IVST has folks! The company has an amazing unchanged=
free-trading float of 11,796,710 common shares with no convertible debts, =
no warrants or options outstanding, and employs 45.
Onto the meat and potatoes:
IVST owns 20% of StemVax Therapeutics which is the first company in its Bio=
tech Division.
StemVax Therapeutics is a Translational Biotechnology Company that develops=
novel therapies for brain tumor patients. We focus our efforts on developi=
ng immunotherapeutic approaches to treating patients with Glioblastoma Mult=
iforme (GBM), a devastating brain cancer. We also focus our research effort=
s on novel drug development to target Cancer Stem cells and other multi-res=
istant cancer cells. Lead by world-renowned neuroscientist, Dr. Dwain Morri=
s-Irvin, the Biotech & Health Sciences Division is currently focused on com=
mercializing StemVax=E2=80=99s cancer vaccination therapy technology. The c=
ancer vaccination therapy technology was just recently awarded a U.S. paten=
t! We seek to make a difference in patient=E2=80=99s lives bringing new beg=
innings to the market by developing novel therapeutics.
IVST=E2=80=99s management team has been extremely busy with its pending meg=
a-acquisition of a building materials company, which produces $30 million i=
n annual revenues! Once the building materials company is acquired, it will=
serve as Innovest Global=E2=80=99s third division. The initial discussions=
began back in March 2018, followed by formal negotiations in April 2018. I=
n June, Innovest management formally proposed the acquisition pitch to the =
target company=E2=80=99s board of directors. Upon conclusion of the present=
ation, both parties had signed and executed a Letter of Intent (LOI) docume=
nt. In late August 2018, it was announced that both parties have effectivel=
y reached an agreement on the acquisition transaction structure and long fo=
rm documents. We expect this to =E2=80=9Cformally=E2=80=9D close at any mom=
ent.
IVST has the vision and model of Berkshire-Hathaway, we look forward to its=
evolution!
Request Removal Here
--b1_1a3ab4d379a91838ba6266608615c1eb
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE html>
<?xml encoding=3D"UTF-8"><html><head></head><body>
<table style=3D"width: 585px; height: 15%;" border=3D"0" width=3D"585" cell=
spacing=3D"0" cellpadding=3D"5" align=3D"center" bgcolor=3D"#dfdfdf"><tbody=
><tr><td valign=3D"center" bgcolor=3D"#dfdfdf">
<p align=3D"right"><span style=3D"font-size: small;"><a style=3D"color: bla=
ck; text-decoration: none;" href=3D"http://ivst.site/web_view.php?id=3DPGQ2=
ZmJkYzI0OTMwOGJhYmE3YjFiNzU0ZDU1NWZkNDk3QGl2c3Quc2l0ZT4%3D" target=3D"_self=
">Trouble viewing this email? Click here to see this message online!</a></s=
pan></p>
</td>
</tr><tr><td valign=3D"top" bgcolor=3D"#ffffff">
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">Innovest =
Global, Inc. </strong><span style=3D"mso-spacerun: yes;"> </span><stro=
ng style=3D"mso-bidi-font-weight: normal;">$IVST</strong> is a diversified =
Public Holding company that is already a ten-bagger this year with much mor=
e on the way based on fundamentals AND technicals!<!--?phpxml:namespace pre=
fix =3D o ns=20
=3D "urn:schemas-microsoft-com:office:office" ?--></span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">IVST</str=
ong> massive breaking news:</span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;">IVST The Board of ‘Authority National Supply’=
Approves Pending Company Sale to IVST by Super Majority Vote, Boosting Inn=
ovest’s Revenue by $30 Million Annually.</span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">Innovest =
Global</strong> Provides Acquisition Update: Authority National Supply Clos=
ing Rescheduled to First Week of November and Secured LOI for $12 Million R=
evenue and Profitable Acquisition in the Building Industry</span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">Innovest =
Global, Inc.</strong> (OTC Markets: <strong style=3D"mso-bidi-font-weight: =
normal;">IVST</strong>) is in the Conglomerates industry, a diversified hol=
ding company with operations in commercial and industrial products and serv=
ices, energy, biotechnology, and health services. Our primary growth strate=
gy is to acquire niche, high-growth businesses that are capable of generati=
ng significant annual revenue. Planned subsidiaries operate across teleheal=
th, biotech, building materials, commercial energy, business-to-business di=
stribution, national call center and auto sales. </span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;">Based out of Cleveland, Ohio, <strong style=3D"mso-bidi-f=
ont-weight: normal;">IVST</strong> is easily one of the better fundamental =
companies trading on the OTC marketplace. <strong style=3D"mso-bidi-font-we=
ight: normal;">Innovest Global, Inc.</strong> is already up 10-fold in 2018=
, after starting off 2018 around $0.02 before shooting to an all-time high =
of $0.50 in March 2018. <strong style=3D"mso-bidi-font-weight: normal;">IVS=
T</strong> continues to hold onto the nice gains thus far holding strong in=
the .25-.30 range ready for the next leg back into the .50 range it tested=
earlier this year. Based upon the company’s strong fundamental AND t=
echnical picture, <strong style=3D"mso-bidi-font-weight: normal;">Innovest =
Global, Inc</strong>. could easily retake its all-time high by the end of 2=
018. </span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;">What a stock structure<strong style=3D"mso-bidi-font-weig=
ht: normal;"> IVST</strong> has folks! The company has an amazing unchanged=
free-trading float of 11,796,710 common shares with <strong style=3D"mso-b=
idi-font-weight: normal;">no</strong> convertible debts,<strong style=3D"ms=
o-bidi-font-weight: normal;"> no</strong> warrants or options outstanding, =
and employs 45. </span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><strong style=3D"mso=
-bidi-font-weight: normal;"><em style=3D"mso-bidi-font-style: normal;"><spa=
n style=3D"font-family: Calibri;">Onto the meat and potatoes:</span></em></=
strong></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">IVST </st=
rong>owns 20% of <strong style=3D"mso-bidi-font-weight: normal;">StemVax Th=
erapeutics</strong> which is the first company in its Biotech Division.</sp=
an></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">StemVax T=
herapeutics</strong> is a Translational Biotechnology Company that develops=
novel therapies for brain tumor patients. We focus our efforts on developi=
ng immunotherapeutic approaches to treating patients with Glioblastoma Mult=
iforme (GBM), a devastating brain cancer. We also focus our research effort=
s on novel drug development to target Cancer Stem cells and other multi-res=
istant cancer cells. Lead by world-renowned neuroscientist, Dr. Dwain Morri=
s-Irvin, the Biotech & Health Sciences Division is currently focused on=
commercializing <strong style=3D"mso-bidi-font-weight: normal;">StemVax&rs=
quo;s</strong> cancer vaccination therapy technology. The cancer vaccinatio=
n therapy technology was just recently awarded a U.S. patent! We seek to ma=
ke a difference in patient’s lives bringing new beginnings to the mar=
ket by developing novel therapeutics.</span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">IVST</str=
ong>’s management team has been extremely busy with its pending mega-=
acquisition of a building materials company, which produces <strong style=
=3D"mso-bidi-font-weight: normal;">$30 million</strong> in annual revenues!=
Once the building materials company is acquired, it will serve as <strong =
style=3D"mso-bidi-font-weight: normal;">Innovest Global’s</strong> th=
ird division. The initial discussions began back in March 2018, followed by=
formal negotiations in April 2018. In June, <strong style=3D"mso-bidi-font=
-weight: normal;">Innovest</strong> management formally proposed the acquis=
ition pitch to the target company’s board of directors. Upon conclusi=
on of the presentation, both parties had signed and executed a Letter of In=
tent (LOI) document. In late August 2018, it was announced that both partie=
s have effectively reached an agreement on the acquisition transaction stru=
cture and long form documents. We expect this to “formally” clo=
se at any moment.</span></p>
<p class=3D"MsoNormal" style=3D"margin: 0in 0in 10pt;"><span style=3D"font-=
family: Calibri;"><strong style=3D"mso-bidi-font-weight: normal;">IVST</str=
ong> has the vision and model of Berkshire-Hathaway, we look forward to its=
evolution!</span></p>
</td>
</tr><tr><td style=3D"height: 50px;" valign=3D"center" height=3D"50">
<p align=3D"center"><span style=3D"font-size: xx-small;"><a href=3D"http://=
ivst.site/unsubscribe.php?id=3DPGQ2ZmJkYzI0OTMwOGJhYmE3YjFiNzU0ZDU1NWZkNDk3=
QGl2c3Quc2l0ZT4%3D">Request Removal Here</a></span></p>
</td>
</tr></tbody></table></body></html>
<div style=3D'float:left; clear:both; font-family:Arial; margin:40px auto; =
width:100%; line-height:175%; font-size:11px; color:#434343'>
=09=09=09=09=09=09=09=09=09=09=09<img border=3D0 src=3D'http://ivst.site/l=
ogo_image.php?id=3DPGQ2ZmJkYzI0OTMwOGJhYmE3YjFiNzU0ZDU1NWZkNDk3QGl2c3Quc2l0=
ZT4%3D' width=3D1 height=3D1 alt=3D''></div>
--b1_1a3ab4d379a91838ba6266608615c1eb--
